Steven C. Borkan receives the NIH RO-1 Grant to Study Ischemic AKI

Dr. Borkan receives the NIH RO-1 award entitled: “Nucleophosmin Centered Diagnostics & Treatment of Ischemic Acute Kidney Injury”. The primary objective of his study is to harness nucleophosmin, a key cell death protein, as a potential rapid diagnostic and effective therapeutic target for ischemic AKI in our patients.